Myriad Genetics Chief Financial Officer Bryan Riggsbee retires; Scott Leffler named successor; reiterates previously issued financial guidance
SALT LAKE CITY, Dec. 21, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Scott Leffler as …